Previous Close | 1.9400 |
Open | 1.9200 |
Bid | 1.9500 x 3200 |
Ask | 1.9700 x 800 |
Day's Range | 1.9200 - 2.0000 |
52 Week Range | 1.7750 - 9.8000 |
Volume | |
Avg. Volume | 212,676 |
Market Cap | 86.689M |
Beta (5Y Monthly) | 0.48 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.6800 |
Earnings Date | Aug 01, 2022 - Aug 05, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 8.83 |
Subscribe to Yahoo Finance Plus to view Fair Value for CTSO
CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, announces management will present at two upcoming in–person investor conferences.
With the business potentially at an important milestone, we thought we'd take a closer look at Cytosorbents...
CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, today reported unaudited financial and operating results for the quarter ended March 31, 2022.